Regeneron agrees CRISPR/Cas licensing deal
14-04-2016
USPTO ignites CRISPR/Cas9 patent battle
13-01-2016
Are the Broad Institute’s CRISPR patents too broad?
29-10-2015
Sararwut Jaimassiri / Shutterstock.com
The US Patent and Trademark Office (USPTO) has opened proceedings to determine who owns the rights to the CRISPR/Cas9 technology.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
CRISPR/Cas9, patent, US Patent and Trademark Office, USPTO, interference proceeding, Broad Institute, Harvard, University of California
